FIELD: medicine.
SUBSTANCE: invention relates to medicine, particularly to haematology and endocrinology, and deals with thrombocyte disorders correction in metabolic syndrome patients. For this purpose individually selected low-calorie diet and drug therapy: 5 mg amlodipine daily, 2 mg perindopryl daily are administered. The therapy course is 24 week.
EFFECT: primary haemostasis normalisation, helping significantly lower the risk of thrombosis complications in metabolic syndrome cases.
1 ex
Authors
Dates
2008-11-27—Published
2007-02-28—Filed